SCHEMBL5758336

SCHEMBL5758336

CC(C)(C(N)=O)c1cccs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.48
KMT2A Q03164 1/20 0.48
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
HDAC1 Q13547 4/20 0.39
HDAC2 Q92769 4/20 0.39
ALOX5 P09917 2/20 0.39
TSHR P16473 1/20 0.39
HDAC3 O15379 3/20 0.38
F2 P00734 2/20 0.38
PRSS1 P07477 2/20 0.38
PRSS2 P07478 2/20 0.38
PRSS3 P35030 2/20 0.38
POLB P06746 1/20 0.38
KIF11 P52732 1/20 0.38
DAO P14920 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492740 0.82 DAO (0.43) MAPTKMT2ACES2CES1HDAC1
SCHEMBL1238423 0.80 CNR1 (0.40) MAPTKMT2AALOX5TSHRKIF11
SCHEMBL9235584 0.80 CNR1 (0.40) KMT2ACES2CES1HDAC1ALOX5
Hydrochloric Acid SCHEMBL9402263 0.80 DAO (0.42) MAPTKMT2ACES2CES1HDAC1
SCHEMBL2986833 0.79 HDAC1 (0.39) KMT2ACES2CES1HDAC1HDAC2
SCHEMBL6675248 0.78 DAO (0.41) MAPTKMT2ACES2CES1ALOX5
SCHEMBL41617 0.78 DAO (0.43) KMT2ACES2CES1HDAC1ALOX5
SCHEMBL1421302 0.78 DAO (0.43) KMT2ACES2CES1HDAC1ALOX5
SCHEMBL599752 0.78 DAO (0.43) KMT2ACES2CES1HDAC1ALOX5
SCHEMBL22394843 0.77 CHRM3 (0.40) MAPTKMT2ACES2CES1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670804-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC Biotech AG (DE) 2006-06-21 EP disclosed
WO-2005023818-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC BIOTECH AG (DE) 2005-03-17 WO disclosed